Novavax
NVAX
#5751
Rank
C$1.55 B
Marketcap
C$9.55
Share price
0.73%
Change (1 day)
-17.97%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of September 2025 : -C$0.22 Billion

According to Novavax's latest financial reports the company has -C$0.22 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-C$0.9 Billion-5.86%
2023-12-31$-C$0.96 Billion10.52%
2022-12-31$-C$0.87 Billion91.98%
2021-12-31$-C$0.45 Billion-156.04%
2020-12-31$C$0.79 B-429.18%
2019-12-31$-C$0.25 Billion6.2%
2018-12-31$-C$0.23 Billion78.86%
2017-12-31$-C$0.13 Billion1616.12%
2016-12-31$-C$7.46 Million-101.84%
2015-12-31$C$0.40 B52.36%
2014-12-31$C$0.26 B23.17%
2013-12-31$C$0.21 B171.14%
2012-12-31$C$79.79 M45.67%
2011-12-31$C$54.77 M-7.2%
2010-12-31$C$59.02 M-19.8%
2009-12-31$C$73.6 M33.07%
2008-12-31$C$55.31 M-12.09%
2007-12-31$C$62.91 M-42.52%
2006-12-31$C$0.10 B89.33%
2005-12-31$C$57.8 M44.61%
2004-12-31$C$39.97 M-14.27%
2003-12-31$C$46.62 M265.68%
2002-12-31$C$12.75 M-70.89%
2001-12-31$C$43.79 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Agenus
AGEN
-C$0.39 Billion 79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$1.82 B-942.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.80 B-471.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$0.54 Billion 147.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$63.50 B-29,442.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$128.61 B-59,520.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$61.82 B-28,664.13%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
C$10.38 M-104.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$29.25 B-13,616.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$0.82 B-481.92%๐Ÿ‡บ๐Ÿ‡ธ USA